Blood cancers, Cell type, Hodgkin lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial compared low dose lenograstim with standard dose lenograstrim after high dose chemotherapy and a stem cell transplant. It recruited people with lymphoma, including Hodgkin lymphoma and non-Hodgkin lymphoma (NHL).
Recruitment start: 1 May 1999
Recruitment end: 1 May 2004
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Linch
Professor John Sweetenham
Haematology Trials Group
Last reviewed: 10 April 2014
CRUK internal database number: 86
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
